Skip to Content

Notice

Regulatory Approach To Products Comprised of Living Autologous Cells Manipulated Ex Vivo and Intended for Structural Repair or Reconstruction; FDA Commissioner's Roundtable; Notice of Public Meeting

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

The full text of this document is currently available in PDF format.

The full text of this document is also available in a basic text format.